Chen M - Search Results

1

EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells.

Wu F, Li N, Wu X, Chen M, Huang W, Chen X, Hong Y, Wang L, Chen K, Lin L, You M, Liu J. Wu F, et al. Among authors: chen k, chen m, chen x. BMC Cancer. 2024 Sep 19;24(1):1166. doi: 10.1186/s12885-024-12950-y. BMC Cancer. 2024. PMID: 39300407 Free PMC article.

2

Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.

Wang LL, Huang WW, Huang J, Huang RF, Li NN, Hong Y, Chen ML, Wu F, Liu J. Wang LL, et al. Kaohsiung J Med Sci. 2020 Aug;36(8):581-591. doi: 10.1002/kjm2.12212. Epub 2020 Apr 20. Kaohsiung J Med Sci. 2020. Retraction in: Kaohsiung J Med Sci. 2024 Oct;40(10):954. doi: 10.1002/kjm2.12790 PMID: 32311203 Free article. Retracted.

3

Tumor mutational burden in non-immunotherapy patients with heavily pretreated metastatic breast cancer: long-term outcomes from a single institution.

Wu F, Chen M, Li N, Wu X, Huang W, Chen X, Chen K, Wang L, Liu J. Wu F, et al. Among authors: chen k, chen m, chen x. J Chemother. 2023 Jul;35(4):348-356. doi: 10.1080/1120009X.2022.2107753. Epub 2022 Aug 24. J Chemother. 2023. PMID: 36000459

4

A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.

Huang W, Wang C, Shen Y, Chen Q, Huang Z, Liu J, Lin X, Wang L, Wu F, Chen X, Li N, Hong Y, Chen M, Li J, Huang C. Huang W, et al. Among authors: chen m, chen q, chen x. BMC Cancer. 2024 Jan 5;24(1):39. doi: 10.1186/s12885-023-11790-6. BMC Cancer. 2024. PMID: 38182995 Free PMC article.

5

Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.

Huang W, Wang C, Shen Y, Chen Q, Huang Z, Liu J, Lin X, Wang L, Wu F, Chen X, Li N, Hong Y, Chen M, Li J, Huang C. Huang W, et al. Among authors: chen m, chen q, chen x. BMC Cancer. 2024 Mar 25;24(1):378. doi: 10.1186/s12885-024-12150-8. BMC Cancer. 2024. PMID: 38528446 Free PMC article. No abstract available.

6

Pseudoprogression After Palbociclib with Aromatase Inhibitors Treatment in Metastatic Breast Cancer.

Huang W, Li C, Chen M, Lin D, Wu F, Chen X, Li N, Wang L, Liu J. Huang W, et al. Among authors: chen m, chen x. Onco Targets Ther. 2020 Aug 5;13:7785-7792. doi: 10.2147/OTT.S253333. eCollection 2020. Onco Targets Ther. 2020. PMID: 32943874 Free PMC article.

7

The Efficacy and Safety of Inetetamab and Pyrotinib in Combination with Vinorelbine for Second-line Therapy and Beyond in HER2-positive Metastatic Breast Cancer: A Single-institution Clinical Experience.

Wu F, Chen M, Wang L, Li N, Wu X, Chen X, Hong Y, Li C, Lin L, Chen K, Huang W, Liu J. Wu F, et al. Among authors: chen k, chen m, chen x. Curr Cancer Drug Targets. 2024;24(5):490-500. doi: 10.2174/0115680096248592231016065117. Curr Cancer Drug Targets. 2024. PMID: 37916639

8

Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study.

Huang W, Wang C, Wang L, Shen Y, Chen Q, Huang Z, Liu J, Lin X, Wu F, Chen X, Li N, Hong Y, Chen M, Li J, Huang C. Huang W, et al. Among authors: chen m, chen q, chen x. Front Cell Dev Biol. 2024 Feb 22;12:1313610. doi: 10.3389/fcell.2024.1313610. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38481526 Free PMC article.

9

Corrigendum to "Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway" [Kaohsiung J Med Sci. 2020;36(8):581-591].

Wang LL, Huang WW, Huang J, Huang RF, Li NN, Hong Y, Chen ML, Wu F, Liu J. Wang LL, et al. Kaohsiung J Med Sci. 2022 Mar;38(3):288. doi: 10.1002/kjm2.12525. Kaohsiung J Med Sci. 2022. PMID: 35286015 Free article. No abstract available.

10

Predicting the Prognosis and Immunotherapeutic Response of Triple-Negative Breast Cancer by Constructing a Prognostic Model Based on CD8+ T Cell-Related Immune Genes.

Li NN, Qiu XT, Xue JS, Yi LM, Chen ML, Huang ZJ. Li NN, et al. Biomed Environ Sci. 2024 Jun 20;37(6):581-593. doi: 10.3967/bes2024.065. Biomed Environ Sci. 2024. PMID: 38988109 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51,449 results

Search Page

Filters